Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts
Tenidap (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phospholipase A2. This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase A2...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1995-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/S0962935195000123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555938085601280 |
|---|---|
| author | W. Pruzanski B. P. Kennedy H. van den Bosch E. Stefanski M. Wloch P. Vadas |
| author_facet | W. Pruzanski B. P. Kennedy H. van den Bosch E. Stefanski M. Wloch P. Vadas |
| author_sort | W. Pruzanski |
| collection | DOAJ |
| description | Tenidap (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phospholipase A2. This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase A2 (sPLA2). Concentrations as low as 0.25 μg/ml (0.725 μM) reduced the release of sPLA2 by 40% from foetal rat calvarial osteoblasts stimulated with IL-1β and TNFα, whereas a concentration of 2.5 μg/ml (7.25 μM) reduced the release by over 80%. TD also markedly reduced the release of sPLA2 from unstimulated cells. There was no direct inhibition of sPLA2 enzymatic activity by TD in vitro. Northern blot analysis showed that TD did not affect the sPLA2 mRNA levels; however, immunoblotting showed a dose-dependent reduction in sPLA2 enzyme. These results, together with a marked reduction in sPLA2 enzymatic activity, suggest that TD inhibits sPLA2 synthesis at the post-transcriptional level. Therefore TD seems to inhibit the arachidonic acid cascade proximally to cyclooxygenase and lipoxygenase and its anti-inflammatory activity may be related at least in part to the inhibition of sPLA2 synthesis. |
| format | Article |
| id | doaj-art-a0f950c75020487b8df230b808ebfbc1 |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 1995-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-a0f950c75020487b8df230b808ebfbc12025-02-03T05:46:44ZengWileyMediators of Inflammation0962-93511466-18611995-01-0141677010.1155/S0962935195000123Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblastsW. Pruzanski0B. P. Kennedy1H. van den Bosch2E. Stefanski3M. Wloch4P. Vadas5lnflammation Research Group, Division of Immunology, Wellesley Hospital, University of Toronto, Toronto, Ontario, M4Y 1J3, CanadaDepartment of Molecular Biology, Merck Frosst Centre for Therapeutic Research, Montreal, H9R 4P8, CanadaCentre for Biomembranes and Lipid Enzymology, University of Utrecht, The Netherlandslnflammation Research Group, Division of Immunology, Wellesley Hospital, University of Toronto, Toronto, Ontario, M4Y 1J3, Canadalnflammation Research Group, Division of Immunology, Wellesley Hospital, University of Toronto, Toronto, Ontario, M4Y 1J3, Canadalnflammation Research Group, Division of Immunology, Wellesley Hospital, University of Toronto, Toronto, Ontario, M4Y 1J3, CanadaTenidap (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phospholipase A2. This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase A2 (sPLA2). Concentrations as low as 0.25 μg/ml (0.725 μM) reduced the release of sPLA2 by 40% from foetal rat calvarial osteoblasts stimulated with IL-1β and TNFα, whereas a concentration of 2.5 μg/ml (7.25 μM) reduced the release by over 80%. TD also markedly reduced the release of sPLA2 from unstimulated cells. There was no direct inhibition of sPLA2 enzymatic activity by TD in vitro. Northern blot analysis showed that TD did not affect the sPLA2 mRNA levels; however, immunoblotting showed a dose-dependent reduction in sPLA2 enzyme. These results, together with a marked reduction in sPLA2 enzymatic activity, suggest that TD inhibits sPLA2 synthesis at the post-transcriptional level. Therefore TD seems to inhibit the arachidonic acid cascade proximally to cyclooxygenase and lipoxygenase and its anti-inflammatory activity may be related at least in part to the inhibition of sPLA2 synthesis.http://dx.doi.org/10.1155/S0962935195000123 |
| spellingShingle | W. Pruzanski B. P. Kennedy H. van den Bosch E. Stefanski M. Wloch P. Vadas Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts Mediators of Inflammation |
| title | Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts |
| title_full | Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts |
| title_fullStr | Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts |
| title_full_unstemmed | Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts |
| title_short | Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts |
| title_sort | tenidap sodium inhibits secretory non pancreatic phospholipase a2 synthesis by foetal rat calvarial osteoblasts |
| url | http://dx.doi.org/10.1155/S0962935195000123 |
| work_keys_str_mv | AT wpruzanski tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts AT bpkennedy tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts AT hvandenbosch tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts AT estefanski tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts AT mwloch tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts AT pvadas tenidapsodiuminhibitssecretorynonpancreaticphospholipasea2synthesisbyfoetalratcalvarialosteoblasts |